Found 0 matching trials
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML PHASE3 A randomized,multicenter, open-label Phase III, clinical study is conducted...
Show More Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Learn More & Join Trial
Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma NA RATIONALE: Lenalidomide may stimulate the immune system in different ways a...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes PHASE2 Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Show More Location
Local Institution - 113
Learn More & Join Trial
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax PHASE1 This phase Ib trial is to find the side effect and best dose of navitoclax ...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome N/A The purpose of this study is to investigate the overall response rate (ORR)...
Show More Location
Multiple Locations
Learn More & Join Trial
Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE1 This phase I trial studies the side effects and the best dose of cytarabine...
Show More Location
Ohio State University Comprehensive Cancer Center
Learn More & Join Trial
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia PHASE1 This phase I trial studies the side effects and immune response to DEC-205/...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy PHASE2 The main aim is to see how the combination of pevonedistat + venetoclax + a...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2 PHASE1 This open-label Phase I study aims to define the recommended dose for furth...
Show More Location
Multiple Locations
Learn More & Join Trial
tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy PHASE2 This is an intervention study to investigate the impact of spinal stimulati...
Show More Location
Shirley Ryan AbilityLab
Learn More & Join Trial